Picard Medical Cash Flow Statement (2024-2026) | PMI

Cash Flow Statement Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -4.06M-6.21M-8.45M-5.56M-6.72M-10.43M-4.30M-7.62M
Depreciation and Depletion (Quarter) 0.02M-0.09M0.02M0.02M0.02M0.02M0.03M
Share-based Compensation (Quarter) 0.43M-0.66M0.14M0.18M1.92M-0.53M1.60M
Asset Writedowns and Impairment (Quarter) -0.46M0.32M-0.22M0.18M
Cash from Operations (Quarter) -2.61M-3.15M-2.24M-2.54M-6.51M-4.38M-3.80M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 1.17M0.27M0.00M
Amortization of Deferred Charges (Quarter) 0.08M0.09M0.09M0.09M0.09M0.09M0.09M
Depreciation & Amortization (CF) (Quarter) 0.04M0.04M0.04M0.44M-0.56M0.04M0.05M
Change in Working Capital
Change in Receivables (Quarter) -0.17M-0.00M-0.51M1.29M-0.41M-0.26M-0.03M
Change in Inventory (Quarter) 0.65M-0.27M0.25M-0.90M-0.27M0.53M0.32M
Change in Account Payables (Quarter) 1.15M0.20M0.23M0.85M-3.25M-1.04M0.63M
Change in Accured Expenses (Quarter) 0.32M0.15M0.32M0.38M-0.38M0.04M0.12M
Other Working Capital Changes (Quarter) -0.24M-0.03M0.14M0.13M
Investing Activities
Capital Expenditures (Quarter) 0.03M
Cash from Investing Activities (Quarter) -0.03M
Financing Activities
Other financing activities (Quarter) 0.04M
Cash from Financing Activities (Quarter) 2.53M3.23M2.83M2.28M8.95M13.02M-7.52M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 0.50M0.98M13.72M
Additional items
Exchange Rate Effect (Quarter) 0.01M0.01M-0.00M-0.01M-0.03M-0.00M0.02M
Change in Cash (Quarter) -0.07M0.09M0.59M-0.28M2.40M8.64M-11.33M
Free Cash Flow (Quarter) -2.61M-3.15M-2.24M-2.54M-6.51M-4.38M-3.83M
Net Cash Flow (Quarter) -0.08M0.08M0.59M-0.26M2.44M8.64M-11.35M